Sharma, Shruti <br/><br/>
Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL.  [electronic resource] 

 -  Oncotarget  Oct 2016 
 - 68833-68841 p.  digital 
<br/><br/> Publication Type: Case Reports; Journal Article 
<br/><br/><label>ISSN: </label>1949-2553 
<br/><br/><label>Standard No.: </label>10.18632/oncotarget.11932  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adenine--analogs & derivatives<br/>Agammaglobulinaemia Tyrosine Kinase<br/>Antineoplastic Agents--therapeutic use<br/>Cell Transformation, Neoplastic<br/>DNA Mutational Analysis<br/>Drug Resistance, Neoplasm<br/>Female<br/>High-Throughput Nucleotide Sequencing<br/>Humans<br/>Leukemia, Lymphocytic, Chronic, B-Cell--drug therapy<br/>Middle Aged<br/>Mutation<br/>Neoplasm Recurrence, Local<br/>Piperidines<br/>Protein Kinase Inhibitors--therapeutic use<br/>Protein-Tyrosine Kinases--genetics<br/>Pyrazoles--therapeutic use<br/>Pyrimidines--therapeutic use<br/>src Homology Domains